Stake sale: Glenmark Pharma to offload 7.84% stake in Glenmark Life Science through OFS

Nirma's purchase of 75% of Glenmark Life Sciences boosts its pharmaceutical industry standing. GLS offers unique APIs for chronic diseases globally. Glenmark Pharma's board sanctioned the sale of 7.84% stake in GLS through an offer for sale on the stock exchange.

Updated10 Jul 2024, 09:55 PM IST
Glenmark Pharmaceuticals
Glenmark Pharmaceuticals(ANI)

New Delhi: Glenmark Pharma board has approved the sale of a 7.84 per cent stake, which is equivalent to 96,09,571 equity shares, in Glenmark Life Sciences, the company said in an exchange filing on June 10. The stake will be sold through the stock exchanges using an offer for sale (OFS).

On Wednesday, July 10, Glenmark Pharmaceuticals stated that the sale of a 7.84 percent ownership in Glenmark Life Sciences Limited (GLS), the company's subsidiary, had been approved by the board of directors. Up to 96,09,571 equity shares may be sold in this transaction, which will take place via an offer for sale (OFS) on the stock exchange.

It is anticipated that the offer for sale's precise price and date will be disclosed later.

The Indian conglomerate Nirma completed the purchase of a 75% interest in Glenmark Life Sciences (GLS), a producer of active pharmaceutical ingredients (APIs), in May of this year.

Nirma's position in the pharmaceutical and life sciences industries is strengthened by the acquisition. Nirma became the promoter of GLS after acquiring 91.9 million equity shares in accordance with the provisions of the share purchase agreement. 75% of GLS's current issued and paid-up equity share capital was acquired from Glenmark Pharmaceuticals.

GLS is a top producer and creator of unique, valuable, and non-commoditized active medicinal components. The 146 compounds in the company's portfolio address chronic treatment areas such as diabetes, pain management, central nervous system disorders, and cardiovascular disease.

GLS partners with 16 of the top 20 generic companies in the world and serves customers in multiple regions, including North America, Europe, Japan, Latin America, India and rest of the world.

With 142 APIs in GLS's portfolio, the company claimed to be blending innovation and operational excellence to deliver on the promise of service, reliability, and consistent product quality and supply high-quality APIs to more than 700 pharma companies in multiple countries.

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.MoreLess
First Published:10 Jul 2024, 09:55 PM IST
HomeCompaniesNewsStake sale: Glenmark Pharma to offload 7.84% stake in Glenmark Life Science through OFS

Most Active Stocks

Tata Steel

03:57 PM | 16 JUL 2024
0.25 (0.15%)

Oil & Natural Gas Corporation

03:58 PM | 16 JUL 2024
-0.15 (-0.05%)

Bandhan Bank

03:41 PM | 16 JUL 2024
2.95 (1.51%)

Coal India

03:59 PM | 16 JUL 2024
14.4 (2.89%)
More Active Stocks

Market Snapshot

  • Top Gainers
  • Top Losers
  • 52 Week High

Natco Pharma

03:59 PM | 16 JUL 2024
73.2 (6.06%)

Century Textiles & Industries

03:48 PM | 16 JUL 2024
116.85 (5.56%)

Tata Teleservices Maharashtra

03:54 PM | 16 JUL 2024
4.23 (5.49%)

India Cements

03:55 PM | 16 JUL 2024
15.8 (5.14%)
More from Top Gainers

Recommended For You

    More Recommendations

    Gold Prices

    • 24K
    • 22K

    Fuel Price

    • Petrol
    • Diesel
    New Delhi
    HomeMarketsCibilPremiumMint Shorts